Faron, etusivu

releases and publications

Result of placing and issue price

Regulatory

Proposed Placing

Regulatory

Notice of Annual General Meeting

Regulatory

AGM to be postponed

Regulatory

Part 1 of the MATINS Phase I/II Study Completed

Regulatory

Correction to Faron´s Annual Report 2019

Regulatory

Faron´s Annual Report 2019 published

Regulatory

Notice of Annual General Meeting

Regulatory

Final Results for the year ended December 31, 2019

Regulatory

FDA accepts protocol for new Traumakine trial

Regulatory
PreviousNext
Back to top